Two Sigma Securities’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,027
| Closed | -$27.5K | – | 1661 |
|
|
2024
Q3 | $27.5K | Buy |
+11,027
| New | +$27.5K | ﹤0.01% | 1202 |
|
|
2024
Q1 | – | Sell |
-11,780
| Closed | -$21.2K | – | 1624 |
|
|
2023
Q4 | $21.2K | Buy |
+11,780
| New | +$21.2K | ﹤0.01% | 1148 |
|
|
2020
Q3 | – | Sell |
-1,869
| Closed | -$15K | – | 632 |
|
|
2020
Q2 | $15K | Buy |
+1,869
| New | +$15K | ﹤0.01% | 519 |
|
|
2019
Q3 | – | Sell |
-1,258
| Closed | -$23K | – | 871 |
|
|
2019
Q2 | $23K | Buy |
+1,258
| New | +$23K | ﹤0.01% | 743 |
|
|
2018
Q4 | – | Sell |
-597
| Closed | -$50K | – | 1305 |
|
|
2018
Q3 | $50K | Buy |
+597
| New | +$50K | ﹤0.01% | 992 |
|
|
2016
Q4 | – | Sell |
-74
| Closed | -$18K | – | 758 |
|
|
2016
Q3 | $18K | Buy |
+74
| New | +$18K | 0.01% | 606 |
|